Exelixis, Inc.

US$69.57As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:EXELHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 20.67%
Div yield —
ROE 44.32%
Biotechnology
Beta (5Y) 0.42
PE TTM 20.78
TSR TTM 79.91%
Mkt cap US$16.98B
ROIC 73.33%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$68
(2.11%)
(9.39%)
Hold 2|8|3|11|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.73
0.70
0.78
0.78
10.07%
8.80%
13.04%
13.67%
Revenue$B
1.382
1.354
1.411
1.409
6.26%
6.46%
7.21%
5.44%
Peers (US$16.98B)
Cap (US$)
PE
16.87B
19.19x
Capital
TTM
5Y
10Y
Leveragex
0.086
(0.075)
(0.066)
EBIT/Intx
0.986
0.184
0.220
Own earn%
(39.90)
69.63
58.59
Sh yield%
7.11
32.16
31.91
Owners
Insiders/Inst%
13.86
45.67
Short interest%
5.29
SBC / revenue%
3.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
24–30
$1 testx
—
Incr. ROIC%
1